Established in 1929
Health City Sun
50¢
The
www.healthcitysun.com
New Mexico’s Legal & Financial Weekly
March 18, 2016
FORECLOSURE SALES: 2 NOTICE OF SUITS: 5
Vol. 6.87 No. 12
PROBATE: 30 AUCTIONS: 6 OTHER: 33 SPANISH NOTICES: 0
Hope For A Cure: Anti-Cancer Compound Looks Promising
*Publish Legal Notices for Less!*
63¢ / line for first week 49¢ / line for additional weeks
F
or the 14 million people who are diagnosed every year with this disease, there are few words more frightening. However, there may be new hope.
Prepaidcopy copy provided provided by: Prepaid by:
According to Propanc Health Group (OTCBB: PPCH), results from a recent study for its lead product, PRP, confirm that its anti-cancer compound has the potential to fight a wide range of cancer types, such as kidney, brain, prostate, liver and lung cancers. The findings are important because up until recently the trend with cancer treatment has been towards ever-costlier drugs aimed at ever-narrower niches on the cancer spectrum, according to an article in The UK Times last month. But recent advancements in immunotherapy and cancer genome sequencing have opened up the possibility that fewer drugs can be used to help the body fight numerous types of cancers. PRP is a naturally derived proenzyme formulation that seeks to halt cancer progression and spreading by eradicating cancer stem cells while leaving normal stem cells unaffected. “I have no doubt PRP represents a new therapeutic drug class with significant potential,” said Dr. Julian Kenyon, Propane’s chief scientific officer. Dr. Kenyon said there is reason to be cautiously optimistic since his previous experience using a proenzyme treatment in the clinic on terminally ill patients suffering from a broad range of cancers helped them survive longer than anticipated, free from any severe, or serious side effects. Propanc said it will submit a clinical trial application in the UK later
TheTime Health City Sun llc. 2012 Prime Publishing 2016
this year, initially targeting patients with advanced solid tumors in Phase I, followed by pancreatic and ovarian cancers in Phase II trials. The trials will allow Propanc to qualify for orphan drug designation, which the company intends to prepare and apply for after its meeting with the Medicines and Healthcare products and Regulatory Agency (MHRA). “Together with the enhancement of our intellectual property and plans to seek orphan drug designation, we’re at the right time to initiate discussions with potential licensing partners looking to add a new therapeutic drug class to their portfolio,” said James Nathanielsz, Propanc’s chief executive officer. Nathanielsz added that currently the company is sufficiently capitalized to fund the early stage development of PRP. According to Global Analyst Reports, the combined world market for pancreatic, ovarian and colorectal cancers is expected to reach more than $12 billion by 2020. To learn more, please visit www.propanc.com. -NewsUSA
Keep Track Of Open Recalls
I
f you’re like most people, car safety and performance are important to you. But you might be surprised to hear that over 47 million vehicles have unfixed safety recalls—vehicles you might be sharing the road with or driving yourself. Alarmingly, family-oriented vehicles like SUVs and minivans are the least-often fixed. An auto recall usually occurs when the manufacturer or the National Highway Traffic Safety Administration finds that a car has a defect or fails to meet federal safety standards. While repeated attempts are made to reach the owners, the stats suggest that people aren’t well-enough informed about recalls, and may not know where to start. To help you stay informed, you can use the
free myCarfax.com service to get e-mails or text alerts about current and future recalls on your car. Fixing recalls helps maintain the safety and value of your car, makes roads safer, and is normally free. Plus, most recall fixes are completed in less than a day. Remember that only a manufacturer’s dealer is authorized to fix recalls. If your car is recalled, call your local dealer immediately. Learn more and sign up at www.mycarfax.com. -(NAPSI)